Literature DB >> 4054515

Early events in duck hepatitis B virus infection. Sequential appearance of viral deoxyribonucleic acid in the liver, pancreas, kidney, and spleen.

M Tagawa, M Omata, O Yokosuka, K Uchiumi, F Imazeki, K Okuda.   

Abstract

Early events in duck hepatitis B virus infection were studied in 1-day-old ducklings following inoculation. Group A ducklings (n = 26) were inoculated intraperitoneally with 10 microliter of infective serum, and group B ducklings (n = 29) were inoculated with 50 microliter. Samples of the serum, liver, pancreas, kidney, and spleen were taken, starting 3 h after inoculation and continuing through the 14th day. In group A, relaxed circular double-stranded deoxyribonucleic acid (DNA) did not appear in serum until day 10, whereas single-stranded DNA, indicative of active replication of the virus, was already demonstrable in the liver on day 6. In group B, single-stranded DNA was first detected in the liver on day 3, and relaxed circular double-stranded DNA became detectable in the liver and serum on day 6. The pancreas started to have single-stranded DNA on day 10 in group A and on day 6 in group B, suggesting active viral replication in this organ soon after it occurred in the liver. In the spleen, relaxed circular double-stranded DNA was detectable when serum became positive for viral DNA, probably due to contamination by serum DNA. However, single-stranded DNA became detectable on day 14 in group A and on day 6 in group B, suggesting a delayed but active viral replication in the constituent tissues of the spleen. These results have demonstrated that active replication of duck hepatitis B virus starts in the liver after infection, and is followed by the pancreas, the kidney, and the spleen. The incubation period is shortened when larger amounts of virus are inoculated, but the sequential occurrence of viral replication in these organs remains the same.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054515

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Lamivudine treatment for recurrent pancreatitis associated with reactivation of chronic B hepatitis.

Authors:  Chien-Hung Chen; Chi-Sin Changchien; Sheng-Nan Lu; Jing-Houng Wang; Chao-Hung Hung; Chuan-Mo Lee
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 2.  Hepatitis B virus. New and evolving issues.

Authors:  B Yoffe; C A Noonan
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

3.  Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues.

Authors:  B E Korba; P J Cote; F V Wells; B Baldwin; H Popper; R H Purcell; B C Tennant; J L Gerin
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus.

Authors:  G Moraleda; J Saputelli; C E Aldrich; D Averett; L Condreay; W S Mason
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Natural history of experimental woodchuck hepatitis virus infection: molecular virologic features of the pancreas, kidney, ovary, and testis.

Authors:  B E Korba; T L Brown; F V Wells; B Baldwin; P J Cote; H Steinberg; B C Tennant; J L Gerin
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection.

Authors:  S Tong; J Li; J R Wands
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.

Authors:  Haitao Guo; Dong Jiang; Tianlun Zhou; Andrea Cuconati; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

8.  Hepatitis B virus replication within the human spleen.

Authors:  A M Di Bisceglie; J H Hoofnagle
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assay.

Authors:  Ayman M Abdelhamed; Colleen M Kelley; Thomas G Miller; Phillip A Furman; Edward E Cable; Harriet C Isom
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions.

Authors:  M A Sells; A Z Zelent; M Shvartsman; G Acs
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.